Publications by authors named "N A Baĭda"

Article Synopsis
  • - The study analyzed the clinical management of multisystem inflammatory syndrome in children (MIS-C) across four hospitals, focusing on treatment variations, patient demographics, and outcomes from March 2020 to March 2021.
  • - Among 233 patients, the most common treatments were steroids, aspirin, IVIG, and anticoagulants, with some patients receiving these treatments in combination; those with respiratory features were less likely to receive both IVIG and steroids simultaneously.
  • - Early administration of IVIG and low-dose steroids was linked to improved patient outcomes, including shorter hospital stays and lower risks of serious complications like ventricular dysfunction and elevated troponin levels.
View Article and Find Full Text PDF

Understanding the serological responses to COVID-19 vaccination in children with history of MIS-C could inform vaccination recommendations. We prospectively enrolled seven children hospitalized with MIS-C and measured SARS-CoV-2 binding IgG antibodies to spike protein variants longitudinally pre- and post-Pfizer-BioNTech BNT162b2 primary series COVID-19 vaccination. We found that SARS-CoV-2 variant cross-reactive IgG antibodies variably waned following acute MIS-C, but were significantly boosted with vaccination and maintained for up to 3 months.

View Article and Find Full Text PDF

Background: Multisystem inflammatory syndrome in children (MIS-C) is a multiorgan hyperinflammatory condition following SARS-CoV-2 infection. Data on COVID-19 vaccine adverse events and vaccine attitudes in children with prior MIS-C are limited. We described characteristics associated with COVID-19 vaccination, vaccine adverse events and vaccine attitudes in children with a history of MIS-C or COVID-19 and their parents/guardians.

View Article and Find Full Text PDF

Within a few years bacteriological knowledge on Burkholderia cepacia species has progressed considerably. Within bacterial classification (taxonomy), B. cepacia gathers eight species and one species on standby of nomenclature (genomovar VI); the whole of these species constitutes the "B.

View Article and Find Full Text PDF

The vernacular name 'fluorescent Pseudomonas group 97-514' was coined for a group of 43 strains isolated from two French natural mineral waters. All these strains were gram-negative, rod-shaped and motile by means of a single polar flagellum. They produced fluorescent pigment (pyoverdin) on King B medium, catalase and cytochrome oxidase.

View Article and Find Full Text PDF